California Retina Associates

California Retina Associates is a specialized medical practice dedicated to the diagnosis and treatment of retinal diseases. Their focus is on providing high-quality care for various eye conditions through advanced technology and expertise. California Retina Associates operates as a specialized medical practice focusing on retinal health and treatment. Founded by Nasrin Mani, the company is based in Chula Vista, US.

It has undergone various growth phases since its inception, striving to incorporate cutting-edge technology in eye care. The company received investment from ShoreView in December 2018, although financial terms were not disclosed. The current CEO is Clay Rempe. The company specializes in offering a wide range of services for diagnosing and treating retinal diseases.

Their core services include advanced diagnostic imaging, surgical treatments, and management of various retinal conditions. California Retina Associates employs state-of-the-art technology to ensure accurate diagnoses and effective treatment plans, catering to patients with diverse needs across North America, Europe, and Asia. California Retina Associates generates revenue through patient services and treatment plans, structured around a fee-for-service model. This model allows for tailored care and treatment options, addressing the specific needs of patients suffering from retinal conditions.

Their focus on comprehensive treatment services likely enhances their revenue stability, as they provide essential medical services to a broad clientele. The company plans to expand its treatment offerings by introducing new diagnostic technologies and surgical procedures aimed at addressing emerging retinal diseases. They are targeting expansions into additional markets within North America and Europe by the end of 2023. The funds from the investment in December 2018 are expected to support these initiatives, allowing for enhanced service delivery and operational expansion.